Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Clemens Hufnagl (First author), Michael Leisch (First author), Lukas Weiss (Co-author), Thomas Melchardt (Co-author), Martin Moik (Co-author), Daniela Asslaber (Co-author), Geisberger Roland, Philipp Steininger (Co-author), Thomas Meissnitzer, Daniel Neureiter (Co-author), Richard Greil (Co-author), Alexander Egle* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1558
JournalOncology Letters
Volume19
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • NUCLEIC-ACIDS
  • LUNG-CANCER
  • COLORECTAL-CANCER
  • PROGNOSTIC-FACTOR
  • LIQUID BIOPSIES
  • SERUM CNAPS
  • RECIST
  • PLASMA
  • CARCINOMA
  • CEA

Cite this